Teriparatide

This classification denotes a recombinant parathyroid hormone with the molecular formula C181H291N55O51S2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 10T9CSU89I, chemically known as l-phenylalanine, l-seryl-l-valyl-l-seryl-l-alpha-glutamyl-l-isoleucyl-l-glutaminyl-l-leucyl-l-methionyl-l-histidyl-l-asparaginyl-l-leucylglycyl-l-lysyl-l-histidyl-l-leucyl-l-asparaginyl-l-seryl-l-methionyl-l-alpha-glutamyl-l-arginyl-l-valyl-l-alpha-glutamyl-l-tryptophyl-l-leucyl-l-arginyl-l-lysyl-l-lysyl-l-leucyl-l-glutaminyl-l-alpha-aspartyl-l-valyl-l-histidyl-l-asparaginyl- but generally known as teriparatide, which bears US NIH Compound Identifier 16129682. European Medicines Agency schedules Teriparatide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10925MIG. The term TERIPARATIDE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 38, No. 6, 1984, List 24). World Health Organization schedules teriparatide in its Anatomical Therapeutic Chemical (ATC) Classification. TERIPARATIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule teriparatide under HS 29371900 and SITC 54154. As of Q4 2014, TERIPARATIDE remains the US FDA Preferred Term for this commodity. Teriparatide bears US NLM identifiers UMLS ID C0070093 and NCI Concept Code C61966. SMILES: S(CCC(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(N)CO)C(C)C)CO)CCC(=O)O)C(CC)C)CCC(=O)N)CC(C)C)C(=O)NC(CC1NC[NH]C1)C(=O)NC(C(=O)NC(CC(C)C)C(=O)NCC(=O)NC(CCCCN)C(=O)NC(C(=O)NC(CC(C)C)C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(C)C)C(=O)N.